Search
Request a Quote

Biocatalytic Route Design and Feasibility

Biocatalysis Process Development Services

Biocatalytic Route Design and Feasibility

Decide whether an enzyme can replace a chemical step before you commit to it.

Route and substrate analysis against your existing chemical step
Enzyme selection from natural and engineered libraries, plus engineering where needed
Small-scale screening, analytical QC, and scale-up feasibility assessment

What Biocatalytic Route Design Is

Biocatalysis uses enzymes as protein catalysts whose active site enables selective chemical transformations, typically under mild aqueous conditions and at or near room temperature. Because the active site controls how a substrate is bound and converted, enzymatic transformations are commonly selective and can deliver enantioselectivity and regioselectivity that are difficult to achieve with conventional chemistry.

Biocatalytic route design and feasibility is the work that happens before a process is committed: identifying or engineering an enzyme that can catalyze the desired bond formation or functional-group conversion, then testing whether that enzyme actually performs on your real substrate and whether the reaction can be scaled into a practical, greener synthesis pathway.

For process chemistry and R&D groups, the question is rarely "is biocatalysis interesting?" It is "can this specific step be replaced, and what would it take?" That is the question this service is built to answer, with data rather than opinion.

Route fit

Substrate and Target-Molecule Analysis

We start from your target molecule and the step you want to change, mapping where an enzymatic transformation could substitute for a chemical reduction or open a new route.

  • Review of the existing synthetic scheme and the candidate step
  • Assessment of substrate structure against known enzyme classes
  • Identification of selectivity or protecting-group problems biocatalysis could relieve
Catalyst

Enzyme Selection and Engineering

Enzymes are no longer limited to a handful of workhorse classes. Modern process biocatalysis draws on oxidoreductases, hydrolases, transferases, and cofactor-recycling systems, and where a wild-type enzyme falls short, engineering can adapt the protein scaffold.

  • Selection from natural and engineered enzyme collections
  • Engineering for activity, selectivity, or stability when needed
  • In silico analysis to guide mutation and library design
Evidence

Feasibility Data, Not Guesswork

Feasibility work tests whether the enzyme performs on the actual substrate and whether the reaction can be scaled. The output is a documented read on technical viability and the parameters that matter for the next stage.

  • Small-scale reaction screening on the real substrate
  • Conversion and selectivity measured by validated analytics
  • Clear go / no-go read with the conditions that drive it

Decision factorWhat we evaluateWhy it changes the routeTypical output
Route fitTarget molecule, candidate step, substrate structureDetermines whether an enzymatic step can substitute or enable a new routeRoute analysis summary with candidate transformations
Selectivity profileChemo-, regio-, and enantioselectivity of the candidate enzymeDrives purity, chiral resolution needs, and downstream burdenMeasured selectivity data on the real substrate
Reaction conditionsWe evaluate pH, temperature, solvent, and the cofactor and cofactor-recycling needs of the candidate enzyme.Sets equipment, safety, and waste-handling requirementsCondition windows that give usable conversion
Analytical readinessConversion and purity methods for the biocatalytic stepWithout reliable analytics, screening results are not decision-gradeTransferred or newly developed assay and QC methods
Scale-up feasibilityEnzyme form, catalyst loading, mixing, and downstream isolationDetermines whether the route survives transfer beyond the benchPreliminary scale-up and process feasibility assessment
SustainabilitySolvent, energy, and metal-content comparison against the chemical stepSupports greener-route claims and regulatory positioningQualitative comparison against the incumbent chemistry

How Engagement Works

Projects move through a defined sequence: a rapid proof-of-concept phase that identifies the first hits, followed by optimization of the enzyme and the reaction toward scale-up. Scope, screening depth, and validation depth are defined in the project SOW after the initial feasibility discussion.

1

Feasibility study and proposal

We evaluate whether biocatalysis is a credible option for the targeted chemical reaction, review the substrate and existing route, and prepare a scoped proposal covering the work plan and decision points.

2

Enzyme selection and sourcing

Candidate enzymes are selected specifically for the target, drawing on natural and engineered collections and, where relevant, on enzyme families known to act on comparable substrates or to support cofactor recycling.

3

Expression and analytical method setup

Selected enzymes are produced in a suitable expression system, and the analytical method is either transferred from your team or developed so that a reliable screening assay can be built on it.

4

Screening assay development and miniaturization

The assay is adapted to miniaturized reaction formats so that a large number of enzymes and reaction conditions can be tested in parallel, with conversion and selectivity read out consistently.

What Can Be Customized

Every route is different, so scope is set case by case rather than from a fixed menu. The table below describes the parameters that are typically adjustable; the exact combination is agreed in the project SOW.

Where a project needs a capability beyond the initial scope, we discuss it at the milestone review rather than forcing it into a predefined bundle.

Screening

Screening Breadth and Depth

The number of enzymes and conditions tested is scoped to the difficulty of the transformation and the maturity of the starting point.

  • Enzyme panel sized to the target and substrate class
  • Miniaturized formats to test many conditions in parallel
  • Iterative rounds when initial hits need refinement
Engineering

Enzyme Engineering Strategy

When a non-natural reaction is targeted, wild-type enzymes sometimes have to be improved to reach performance compatible with industrialization.

  • Semi-rational design combining in silico modeling with variant screening
  • Targeted modification of residues around the active site
  • Adaptation for temperature, solvent, or salt tolerance as required
Process

Reaction and Process Optimization

Once hits are identified, conditions are refined toward a process that can be transferred, including the enzyme-to-substrate and cofactor balance.

  • Primary and secondary physicochemical parameter screening
  • Design of Experiments where the parameter space warrants it
  • Immobilization or formulation considered for reuse and stability

ParameterTypical project scopeNotesSupport
Route analysisTarget molecule and candidate step review; route-fit assessmentIncludes comparison against the incumbent chemical stepA named scientific contact is assigned at project start, milestone review calls are scheduled, and email inquiries receive a response within 1 business day.
Enzyme sourcingSelection from natural and engineered collections, scoped to the targetPanel size agreed in the SOW based on substrate difficultyA named scientific contact is assigned at project start, milestone review calls are scheduled, and email inquiries receive a response within 1 business day.
Enzyme engineeringSemi-rational design and variant screening when wild-type performance is insufficientApplied selectively, not as a default first stepA named scientific contact is assigned at project start, milestone review calls are scheduled, and email inquiries receive a response within 1 business day.
ScreeningMiniaturized reaction screening across enzymes and conditionsAssay built on transferred or newly developed analyticsA named scientific contact is assigned at project start, milestone review calls are scheduled, and email inquiries receive a response within 1 business day.
Reaction optimizationThe team refines pH, temperature, solvent, and cofactor balance as part of reaction optimization.Design of Experiments applied where the parameter space warrants itA named scientific contact is assigned at project start, milestone review calls are scheduled, and email inquiries receive a response within 1 business day.
Analytical QCConversion and purity methods for the biocatalytic stepMethod transfer or development, agreed per projectA named scientific contact is assigned at project start, milestone review calls are scheduled, and email inquiries receive a response within 1 business day.
Scale-up feasibilityPreliminary assessment of enzyme form, loading, isolation, and transferIncludes immobilization or formulation options for reuseA named scientific contact is assigned at project start, milestone review calls are scheduled, and email inquiries receive a response within 1 business day.
Sustainability reviewQualitative comparison of solvent, energy, and metal content against the chemical routeSupports greener-route positioningA named scientific contact is assigned at project start, milestone review calls are scheduled, and email inquiries receive a response within 1 business day.

Deliverables and Documentation

Deliverables are defined in the SOW and typically include the data and documentation needed to make a route decision and to plan the next stage of development.

Where a project progresses to process development, documentation is prepared to support transfer and further scale-up work.

Data

Feasibility Readout

A documented assessment of whether the biocatalytic step is technically viable for the target, with the conditions and enzyme candidates that support the conclusion.

  • Conversion and selectivity data on the real substrate
  • Identified hits and the conditions that produced them
  • Clear statement of remaining technical risk
Materials

Enzyme and Sample Supply

Enzyme material and, where scoped, compound supply to support your own follow-up studies, with analytical documentation accompanying supplied material.

  • Enzyme material at the quantity agreed in the SOW
  • Compound supply with analytical documentation where scoped
  • Support for your own internal evaluation work
Transfer

Process Documentation

Process documentation and support for transfer are typical outcomes of a collaboration, tailored to the receiving site and the stage of development.

  • Process description covering conditions and parameters
  • Support for scale-up facility assessment where scoped
  • Documentation aligned to the agreed project milestones

Comparison With the Chemical Step

The comparison below reflects the general characteristics of biocatalytic versus conventional chemical transformations. Actual outcomes depend on the specific substrate, enzyme, and process, and are established during feasibility work rather than assumed.

Where a biocatalytic route does not show a credible advantage, the feasibility assessment will say so.

AspectBiocatalytic routeConventional chemical stepWhat feasibility work establishes
SelectivityActive-site control commonly delivers chemo-, regio-, and enantioselectivitySelectivity often requires ligands, protecting groups, or chiral resolutionMeasured selectivity on the real substrate
ConditionsTypically mild aqueous conditions at or near room temperatureOften elevated temperature, anhydrous solvent, or metal complexesCondition window that gives usable conversion
Solvent and wasteWater as the major solvent; enzymes are biodegradable catalystsHazardous and fossil-fuel-dependent solvents are commonQualitative solvent and waste comparison
Metal contentNo or residual metal content requiredTransition-metal catalysts and ligands drive cost and supply dependencyAssessment of metal-related constraints for the target
Step countEnzymes can combine multiple synthetic steps, including cascades in one potMulti-step sequences with intermediate isolationRoute comparison at the scheme level
Development pathRequires enzyme selection or engineering and process optimizationEstablished unit operations and known scale-up behaviorRealistic development effort and risk profile

Where This Fits

This service is most useful when a specific step is under pressure, whether from selectivity problems, solvent or waste constraints, or supply dependency on a metal catalyst.

It is also used earlier, when a route is still being designed and the team wants to know whether an enzymatic option is worth building into the scheme.

Replacement

Replacing a Chemical Reduction

When a reduction step is costly, poorly selective, or hard to control, feasibility work tests whether an enzymatic alternative can deliver the required selectivity under milder conditions.

  • Assessment against the existing step's selectivity profile
  • Cofactor and recycling requirements evaluated early
  • Comparison of conditions and downstream impact
New route

Enabling a New Synthetic Route

Some target molecules are difficult to reach with conventional chemistry. Enzyme catalysis can open transformations that are impractical or uneconomical by other means.

  • Evaluation of non-natural transformations
  • Engineering applied where wild-type enzymes fall short
  • Route design from target molecule backward to catalyst
Cofactor

NAD(P)H Regeneration and Cofactor Strategy

Many oxidoreductase-based steps depend on cofactor supply. Feasibility work addresses cofactor requirements and recycling as part of the route rather than as a separate problem.

  • Cofactor needs identified during route analysis
  • Recycling options considered alongside the main transformation
  • Impact on process economics assessed qualitatively

Getting Started

Engagement typically begins with a feasibility discussion covering the target molecule, the step under consideration, and any analytical methods already in place. From there, a scoped proposal is prepared with defined decision points.

Confidentiality is established before detailed route information is exchanged, so early discussions can be specific rather than generic.

FAQ

How do you decide whether an enzymatic route is worth pursuing?

We start from the target molecule and the specific step in question, then assess whether a known enzyme class can plausibly act on that substrate and deliver the required selectivity. If the answer is not clear from existing enzyme families, we look at whether engineering could close the gap. The feasibility study is designed to give a documented read on technical viability rather than a general opinion on biocatalysis.

What happens if no natural enzyme works on our substrate?

That is a common situation, particularly for non-natural transformations. When wild-type enzymes do not reach performance compatible with industrialization, enzyme engineering can adapt the protein scaffold to the target substrate or to the required conditions, such as temperature or salt tolerance. This is applied selectively, based on the screening results, rather than as a default first step.

Do we need to supply an analytical method?

Not necessarily. If you provide a method, it can be transferred and used as the basis for the screening assay. If you do not have one, we develop an analytical method suitable for measuring conversion and selectivity, then adapt it to a miniaturized format so that a large number of enzymes and conditions can be tested in parallel.

How does cofactor supply affect feasibility?

For oxidoreductase-based steps, cofactor requirements are part of the route assessment rather than a separate consideration. Cofactor needs and recycling options are evaluated alongside the main transformation, because they influence catalyst loading, reaction design, and the practical viability of the step at scale. Where cofactor recycling is required, it is built into the process concept from the start.

Can the biocatalytic step be scaled beyond the bench?

Scale-up feasibility is assessed as part of the work, covering enzyme form, catalyst loading, mixing, and downstream isolation. Where immobilization or formulation would improve reuse and stability, that is considered during optimization. The output is a preliminary assessment of whether the route can be transferred, together with the parameters that need attention at larger scale.

How is the work scoped and reported?

Scope is defined case by case in the project SOW, covering screening breadth, engineering effort, analytics, and validation depth. Reporting is tied to agreed milestones, with a named scientific contact from project start, milestone review calls, and email response within one business day. Process documentation and transfer support are typical outcomes where a project progresses toward scale-up.

References

  1. Sardana M, Mühlfenzl KS, Wenker STM, et al. Exploring the enzyme-catalyzed synthesis of isotope labeled cyclopropanes. Journal of labelled compounds & radiopharmaceuticals. 2022;65(4):86-100. View on PubMed
  2. Liu Y, Li Y, Wu H, et al. Robust Oxidase-Mimetic Supramolecular Nanocatalyst for Lignin Biodegradation. Nano letters. 2024;24(8):2520-2528. View on PubMed
  3. Szerlauth A, Varga Á, Madácsy T, et al. Confinement of Triple-Enzyme-Involved Antioxidant Cascade in Two-Dimensional Nanostructure. ACS materials letters. 2023;5(2):565-573. View on PubMed
  4. Zhang W, Han Y, Yang F, et al. A customized self-assembled synergistic biocatalyst for plastic depolymerization. Journal of hazardous materials. 2024;477:135380. View on PubMed
  5. Zhang Z, Gao L, Boes A, et al. An enzymatic continuous-flow reactor based on a pore-size matching nano- and isoporous block copolymer membrane. Nature communications. 2024;15(1):3308. View on PubMed

Assess your route before you commit to it

Share the target molecule and the step you are considering, and we will outline a feasibility approach covering enzyme selection, selectivity, cofactor needs, and scale-up considerations.

Start a feasibility discussion

Online Inquiry

For research and industrial use only, not for personal medicinal use.

Submit